首页|期刊导航|肿瘤学与转化医学（英文）|Systemic immune-inflammation index as a prognostic indicator in patients with advanced non-small cell lung cancer receiving first-line chemotherapy combined with immunotherapy
Systemic immune-inflammation index as a prognostic indicator in patients with advanced non-small cell lung cancer receiving first-line chemotherapy combined with immunotherapy
Meifeng Luo Cuiyun Su Shaozhang Zhou Shichao Wu Huiting Wei Ruiling Ning Wei Jiang Yun Zhao Xiaoya Huang Shubin Chen Moqin Qiu
肿瘤学与转化医学（英文）2025，Vol.11Issue(3)：138-145,8.
肿瘤学与转化医学（英文）2025，Vol.11Issue(3)：138-145,8.DOI:10.1097/ot9.0000000000000081
Systemic immune-inflammation index as a prognostic indicator in patients with advanced non-small cell lung cancer receiving first-line chemotherapy combined with immunotherapy
Systemic immune-inflammation index as a prognostic indicator in patients with advanced non-small cell lung cancer receiving first-line chemotherapy combined with immunotherapy
摘要
关键词
Systemic immune-inflammation index/Marker/Survival/Non-small cell lung cancer/ImmunotherapyKey words
Systemic immune-inflammation index/Marker/Survival/Non-small cell lung cancer/Immunotherapy引用本文复制引用
Meifeng Luo,Cuiyun Su,Shaozhang Zhou,Shichao Wu,Huiting Wei,Ruiling Ning,Wei Jiang,Yun Zhao,Xiaoya Huang,Shubin Chen,Moqin Qiu..Systemic immune-inflammation index as a prognostic indicator in patients with advanced non-small cell lung cancer receiving first-line chemotherapy combined with immunotherapy[J].肿瘤学与转化医学（英文）,2025,11(3):138-145,8.基金项目
This study was supported by grants from the"Joint Project on Re-gional High-Incidence Diseases Research of Guangxi Natural Science Foundation"under Grant No.2023JJA141341 and the"Guangxi Medical and Health Key Discipline Construction Project."The funders had no role in the design of the study （）
in the collection,analy-ses,or interpretation of data （）
in the writing of the manuscript （）
or in the decision to publish the results. （）
